Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal versus intramuscular hepatitis B vaccination in incident hemodialysis patients
ACTRN12609000616279Phase 4Completed
- Sponsor
- Nefrologia
- Start
- Aug 2003
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by Nefrologia. Primary endpoint: Antibody titers to hepatitis B surface antigen (anti-HBs). Started Aug 2003; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ACTRN12609000616279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000616279.